Latest BML Capital Management, LLC Stock Portfolio
$151Million
Equity Portfolio Value
Last Reported on: 24 Apr, 2024
About BML Capital Management, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $132 Millions as of 31 Dec, 2023.
The top stock holdings of BML Capital Management, LLC are DMXF, BIL, AVIR. The fund has invested 20.5% of it's portfolio in ISHARES TR and 13.8% of portfolio in SPDR SER TR.
The fund managers got completely rid off TALARIS THERAPEUTICS INC (TALS), PASSAGE BIO INC (PASG) and RETRACTABLE TECHNOLOGIES INC (RVP) stocks. They significantly reduced their stock positions in ATHIRA PHARMA INC (ATHA). BML Capital Management, LLC opened new stock positions in TOURMALINE BIO INC, THESEUS PHARMACEUTICALS INC (THRX) and DESIGN THERAPEUTICS INC (DSGN). The fund showed a lot of confidence in some stocks as they added substantially to RAIN ONCOLOGY INC (RAIN), CALCIMEDICA INC and MILESTONE PHARMACEUTICALS IN (MIST).
The top stock holdings of BML Capital Management, LLC are DMXF, BIL, AVIR. The fund has invested 20.5% of it's portfolio in ISHARES TR and 13.8% of portfolio in SPDR SER TR.
The fund managers got completely rid off TALARIS THERAPEUTICS INC (TALS), PASSAGE BIO INC (PASG) and RETRACTABLE TECHNOLOGIES INC (RVP) stocks. They significantly reduced their stock positions in ATHIRA PHARMA INC (ATHA). BML Capital Management, LLC opened new stock positions in TOURMALINE BIO INC, THESEUS PHARMACEUTICALS INC (THRX) and DESIGN THERAPEUTICS INC (DSGN). The fund showed a lot of confidence in some stocks as they added substantially to RAIN ONCOLOGY INC (RAIN), CALCIMEDICA INC and MILESTONE PHARMACEUTICALS IN (MIST).
New Buys
| Ticker | $ Bought |
|---|---|
| ADVERUM BIOTECHNOLOGIES INC | 11,780,300 |
| INSTIL BIO INC | 3,766,340 |
| PMV PHARMACEUTICALS INC | 2,221,030 |
| LENZ THERAPEUTICS INC | 1,427,240 |
| Q32 BIO INC | 424,194 |
| ALLOVIR INC | 151,330 |
New stocks bought by BML Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ACLARIS THERAPEUTICS INC | 1,338 |
| RENEO PHARMACEUTICALS INC | 65.72 |
| MILESTONE PHARMACEUTICALS IN | 37.03 |
| CYTEIR THERAPEUTICS INC | 12.43 |
| CALCIMEDICA INC | 10.31 |
| KINNATE BIOPHARMA INC | 6.54 |
| LISATA THERAPEUTICS INC | 5.5 |
| ATEA PHARMACEUTICALS INC | 1.37 |
Additions to existing portfolio by BML Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ATHIRA PHARMA INC | -38.12 |
| ORAMED PHARMACEUTICALS INC | -33.06 |
| DESIGN THERAPEUTICS INC | -14.57 |
| CONNECT BIOPHARMA HLDGS LTD | 0.00 |
BML Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| RAIN ONCOLOGY INC | -1,618,810 |
| THESEUS PHARMACEUTICALS INC | -4,488,700 |
| ADVERUM BIOTECHNOLOGIES INC | -3,428,440 |
| TOURMALINE BIO INC | -6,427,190 |
| GRAPHITE BIO INC | -1,172,230 |
| HOMOLOGY MEDICINES INC | -454,850 |
| NEUROGENE INC | -478,027 |
BML Capital Management, LLC got rid off the above stocks
Current Stock Holdings of BML Capital Management, LLC
Last Reported on: 24 Apr, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ABIO | ARCA BIOPHARMA INC | 0.82 | 706,930 | 1,244,200 | UNCHANGED | 0.00 | |
| ACRS | ACLARIS THERAPEUTICS INC | 7.68 | 9,395,930 | 11,651,000 | ADDED | 1,338 | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 7.77 | 833,117 | 11,780,300 | NEW | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ALVR | ALLOVIR INC | 0.10 | 200,464 | 151,330 | NEW | ||
| ASTC | ASTROTECH CORP | 1.30 | 220,410 | 1,972,650 | UNCHANGED | 0.00 | |
| ATHA | ATHIRA PHARMA INC | 1.63 | 900,000 | 2,466,000 | REDUCED | -38.12 | |
| AVIR | ATEA PHARMACEUTICALS INC | 14.75 | 5,536,710 | 22,368,300 | ADDED | 1.37 | |
| AVRO | AVROBIO INC | 3.38 | 4,001,630 | 5,122,080 | UNCHANGED | 0.00 | |
| BIL | SPDR SER TR | 12.11 | 200,000 | 18,360,000 | UNCHANGED | 0.00 | |
| CLBS | LISATA THERAPEUTICS INC | 0.59 | 284,669 | 888,167 | ADDED | 5.5 | |
| CNTB | CONNECT BIOPHARMA HLDGS LTD | 2.37 | 2,061,340 | 3,586,730 | REDUCED | 0.00 | |
| CYT | CYTEIR THERAPEUTICS INC | 7.25 | 3,654,050 | 10,998,700 | ADDED | 12.43 | |
| DMXF | ISHARES TR | 17.93 | 270,000 | 27,191,700 | UNCHANGED | 0.00 | |
| DSGN | DESIGN THERAPEUTICS INC | 2.34 | 879,478 | 3,544,300 | REDUCED | -14.57 | |
| ELYM | ELIEM THERAPEUTICS INC | 3.96 | 2,193,740 | 6,010,850 | ADDED | 0.63 | |
| FBRX | FORTE BIOSCIENCES INC | 0.81 | 1,761,700 | 1,226,500 | UNCHANGED | 0.00 | |
| FIXX | HOMOLOGY MEDICINES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GRPH | GRAPHITE BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KNTE | KINNATE BIOPHARMA INC | 0.88 | 498,851 | 1,326,940 | ADDED | 6.54 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 0.72 | 606,145 | 1,085,000 | ADDED | 37.03 | |
| NXTC | NEXTCURE INC | 0.45 | 306,465 | 683,417 | UNCHANGED | 0.00 | |
| ORMP | ORAMED PHARMACEUTICALS INC | 1.63 | 844,496 | 2,465,930 | REDUCED | -33.06 | |
| PMVP | PMV PHARMACEUTICALS INC | 1.47 | 1,306,490 | 2,221,030 | NEW | ||
| RAIN | RAIN ONCOLOGY INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RPHM | RENEO PHARMACEUTICALS INC | 2.38 | 2,177,910 | 3,615,340 | ADDED | 65.72 | |
| THRX | THESEUS PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TIL | INSTIL BIO INC | 2.48 | 348,735 | 3,766,340 | NEW | ||
| TLIS | TALIS BIOMEDICAL CORP | 0.25 | 42,743 | 374,001 | UNCHANGED | 0.00 | |
| VRCA | VERRICA PHARMACEUTICALS INC | 0.70 | 180,000 | 1,065,600 | UNCHANGED | 0.00 | |
| VSTA | VISTAGEN THERAPEUTICS INC | 0.52 | 150,000 | 792,000 | UNCHANGED | 0.00 | |
| LENZ THERAPEUTICS INC | 0.94 | 63,916 | 1,427,240 | NEW | |||
| ENLIVEN THERAPEUTICS INC | 0.58 | 50,100 | 881,259 | ADDED | 0.2 | ||
| CALCIMEDICA INC | 0.44 | 160,424 | 667,364 | ADDED | 10.31 | ||
| Q32 BIO INC | 0.28 | 24,894 | 424,194 | NEW | |||
| TOURMALINE BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | ||
| NEUROGENE INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |